The Use of Levamisole in Atopic Dermatitis: A Prospective Study

Agustín Alomar, José M. Giménez Camarasa, José M. Moragas

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)


Levamisole hydrochloride, a nonspecific immunostimulant, was given to 30 children with atopic dermatitis (AD) in a double-blind manner during an eightmonth period. Clinical course findings, including intradermal reactions to tuberculin, candidin, and streptokinase-streptodornase; sensitization to dinitrochlorobenzene; peripheral blood T- and Blymphocytes; in vitro lymphocyte transformation with phytohemagglutinin; and serum levels of IgM, IgG, IgA, and IgE, were noted every two months. Fifteen children completed the study. Neither the clinical course nor the immunologic values showed substantial differences between the levamisole-treated and the placebo group. Our experience with levamisole in AD is disappointing. © by Walterde Gruyter & Co.
Original languageEnglish
Pages (from-to)1316-1319
JournalArchives of Dermatology
Issue number9
Publication statusPublished - 1 Jan 1978


Dive into the research topics of 'The Use of Levamisole in Atopic Dermatitis: A Prospective Study'. Together they form a unique fingerprint.

Cite this